Skip to main content

Inhibikase Therapeutics, Inc.

IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750149

No open-market purchases or sales by Inhibikase Therapeutics, Inc. insiders were filed in the last 90 days; 105 institutions reported holding it in 13F filings for Q2 2026, worth $239.2M in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Inhibikase Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+1 vs. Q1 2025
Shares held
54.5M
+3.05M (+5.9%) vs. Q1 2025
Total value
$106.3M
−$6.40M (−5.7%) vs. Q1 2025
New holders
24
11 more added
Sold out
23
6 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 48 institutions
Q1 2021: 9 institutionsQ2 2021: 14 institutionsQ3 2021: 21 institutionsQ4 2021: 26 institutionsQ1 2022: 24 institutionsQ2 2022: 22 institutionsQ3 2022: 24 institutionsQ4 2022: 19 institutionsQ1 2023: 17 institutionsQ2 2023: 14 institutionsQ3 2023: 13 institutionsQ4 2023: 11 institutionsQ1 2024: 12 institutionsQ2 2024: 12 institutionsQ3 2024: 11 institutionsQ4 2024: 31 institutionsQ1 2025: 47 institutionsQ2 2025: 48 institutionsQ3 2025: 54 institutionsQ4 2025: 74 institutionsQ1 2026: 104 institutionsQ2 2026: 105 institutions
Value heldQ2 2025: $106.3M
Q1 2021: $975.0KQ2 2021: $10.6MQ3 2021: $7.78MQ4 2021: $6.85MQ1 2022: $6.33MQ2 2022: $2.49MQ3 2022: $2.78MQ4 2022: $719.4KQ1 2023: $2.91MQ2 2023: $2.69MQ3 2023: $597.6KQ4 2023: $298.9KQ1 2024: $443.8KQ2 2024: $1.02MQ3 2024: $1.12MQ4 2024: $162.7MQ1 2025: $112.7MQ2 2025: $106.3MQ3 2025: $89.0MQ4 2025: $218.2MQ1 2026: $193.4MQ2 2026: $239.2M
Institutions holding IKT and their total value by quarter
QuarterHoldersValue
Q2 2026105$239.2M
Q1 2026104$193.4M
Q4 202574$218.2M
Q3 202554$89.0M
Q2 202548$106.3M
Q1 202547$112.7M
Q4 202431$162.7M
Q3 202411$1.12M
Q2 202412$1.02M
Q1 202412$443.8K
Q4 202311$298.9K
Q3 202313$597.6K
Q2 202314$2.69M
Q1 202317$2.91M
Q4 202219$719.4K
Q3 202224$2.78M
Q2 202222$2.49M
Q1 202224$6.33M
Q4 202126$6.85M
Q3 202121$7.78M
Q2 202114$10.6M
Q1 20219$975.0K

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Inhibikase Therapeutics, Inc.; share changes are against Q1 2025.

Institutions holding IKT in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Sands Capital Ventures, LLC10,950,000$21.4M4.20%00.0%Unchanged
Soleus Capital Management, L.P.6,325,000$12.3M0.85%00.0%Unchanged
Fairmount Funds Management LLC6,125,000$11.9M1.55%00.0%Unchanged
Perceptive Advisors LLC5,432,293$10.6M0.40%−492,707−8.3%Reduced
Commodore Capital LP5,397,488$10.5M0.74%+53,056+1.0%Added
ADAR1 Capital Management, LLC5,122,105$9.99M1.62%00.0%Unchanged
Vanguard Group Inc3,224,370$6.29M0.00%+375,707+13.2%Added
BlackRock, Inc.2,728,168$5.32M0.00%+2,304,189+543.5%Added
Blackstone Group Inc.2,638,276$5.14M0.02%+567,592+27.4%Added
Nantahala Capital Management, LLC2,190,000$4.27M0.30%00.0%Unchanged
Geode Capital Management, LLC1,066,700$2.08M0.00%+741,940+228.5%Added
Stonepine Capital Management, LLC733,793$1.43M1.41%−181,180−19.8%Reduced
State Street Corp397,812$775.7K0.00%+355,928+849.8%Added
Northern Trust Corp392,716$765.8K0.00%+328,705+513.5%Added
Susquehanna International Group, LLP383,071$747.0K0.00%−121,554−24.1%Reduced
Blair William & Co156,953$306.1K0.00%+1,000+0.6%Added
Charles Schwab Investment Management Inc152,298$297.0K0.00%+152,298New
FMR LLC144,239$281.3K0.00%+144,239New
Bank of New York Mellon Corp132,473$258.3K0.00%+132,473New
Barclays PLC110,252$215.0K0.00%+26,252+31.3%Added
Morgan Stanley99,678$194.4K0.00%+78,032+360.5%Added
Nuveen, LLC78,659$153.4K0.00%+78,659New
New York State Common Retirement Fund60,700$118.4K0.00%+60,700New
Rhumbline Advisers58,524$114.1K0.00%+58,524New
UBS Group AG38,674$75.4K0.00%−6,592−14.6%Reduced
Wells Fargo & Company38,326$74.7K0.00%+38,159+22,849.7%Added
Mirae Asset Global ETFs Holdings Ltd.33,023$64.4K0.00%+33,023New
Intech Investment Management LLC31,406$61.2K0.00%+31,406New
LMR Partners LLP31,092$60.6K0.00%00.0%Unchanged
Price T Rowe Associates Inc30,606$60.0K0.00%+30,606New
Invesco Ltd.30,712$59.9K0.00%+30,712New
JPMorgan Chase & Co28,579$55.7K0.00%+28,579New
Citigroup Inc20,393$39.8K0.00%−5,372−20.8%Reduced
Bank of America Corp19,216$37.5K0.00%−25,810−57.3%Reduced
Voya Investment Management LLC18,755$36.6K0.00%+18,755New
Police & Firemen's Retirement System of New Jersey17,638$34.4K0.00%+17,638New
Caxton Corp16,393$32.0K0.32%00.0%Unchanged
ProShare Advisors LLC12,401$24.2K0.00%+12,401New
Buckingham Strategic Partners10,708$20.9K0.00%+10,708New
BNP Paribas Arbitrage, SA9,182$17.9K0.00%+9,182New
Ameritas Investment Partners, Inc.6,174$12.0K0.00%+6,174New
Legal & General Group Plc5,504$10.7K0.00%+5,504New
Royal Bank of Canada4,587$10.0K0.00%+4,587New
California State Teachers Retirement System3,773$7.36K0.00%+3,773New
Amalgamated Bank2,065$4.00K0.00%+2,065New
Sterling Capital Management LLC1,505$2.94K0.00%+1,505New
Raymond James Financial Inc1,000$1.95K0.00%+1,000New
Tower Research Capital LLC (TRC)100$1950.00%+100New
Millennium Management LLC0$00.00%−913,502−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−166,025−100.0%Sold out
Marshall Wace, LLP0$00.00%−155,270−100.0%Sold out
Jane Street Group, LLC0$00.00%−116,249−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−81,161−100.0%Sold out
HRT Financial LP0$00.00%−65,906−100.0%Sold out
Omers Administration Corp0$00.00%−56,000−100.0%Sold out
Jain Global LLC0$00.00%−54,845−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−35,625−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−32,538−100.0%Sold out
Diametric Capital, LP0$00.00%−28,366−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−26,775−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−16,876−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−14,976−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−14,800−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−13,712−100.0%Sold out
Stifel Financial Corp0$00.00%−13,129−100.0%Sold out
Quantessence Capital LLC0$00.00%−13,005−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−11,098−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−11,067−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−10,384−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−9,043−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−1,980−100.0%Sold out